Prevalence of psychotic symptoms in a community-based Parkinson disease sample - Wikidata - wikimedia - TriplyDB

Prevalence of psychotic symptoms in a community-based Parkinson disease sample

Prevalence of psychotic symptoms in a community-based Parkinson disease sample

http://www.wikidata.org/entity/Q35201060

about

The characteristic features of auditory verbal hallucinations in clinical and nonclinical groups: state-of-the-art overview and future directions.Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosis Measuring the lifespace of people with Parkinson's disease using smartphones: proof of principle Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Hallucinations and conscious access to visual inputs in Parkinson's disease Pimavanserin (Nuplazid): A Treatment for Hallucinations and Delusions Associated With Parkinson's Disease.Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder.A comprehensive review of auditory verbal hallucinations: lifetime prevalence, correlates and mechanisms in healthy and clinical individuals.Are patients with Parkinson's disease blind to blindsight?Treating psychosis in movement disorder patients: a review.Psychiatric Conditions in Parkinson Disease: A Comparison With Classical Psychiatric Disorders.Pareidolias in REM Sleep Behavior Disorder: A Possible Predictive Marker of Lewy Body Diseases?Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.The psychosis spectrum in Parkinson disease.Current Understanding of Psychosis in Parkinson's Disease.New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.Psychosis in parkinsonism: an unorthodox approach.Xadago (Safinamide): A Monoamine Oxidase B Inhibitor for the Adjunct Treatment of Motor Symptoms in Parkinson's Disease.Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.Managing psychosis in Parkinson's disease without drugs.Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression.Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care.The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson's disease.Parkinson's disease psychosis: presentation, diagnosis and management.

P2860

Q26866412-F95AC03D-AEAB-4211-B6A1-786736841DB4 Q28074468-1517D61D-9017-4F3D-8AB1-C91636916A9A Q28655145-61316850-EA37-4D5E-B316-1EB0167B464E Q30249553-B1B938A5-628E-4D54-ACBC-E498A320F8E0 Q30828496-4416164A-C24B-45EA-9EBE-C11D81673267 Q33714196-9546D799-65DA-492B-AB97-FEB3CE3EC0AC Q36763240-F0598246-45AB-40C5-A498-203866ECA999 Q37015584-53100891-27B8-4028-92B3-FE16D8BB9FB9 Q38207009-54AF4C4A-5F44-4588-AB60-719FD36A7C56 Q38213306-967755FA-8D6B-474E-BF3F-D7A90F4AE129 Q38588201-4818A618-8367-4F79-BFC8-16F2A5360989 Q38736816-6237AC16-0956-4582-9823-30179FE26CAA Q38743255-948C7526-CAD4-41AE-A17E-33AD5F952CB3 Q38768169-F3358933-8FA9-4A1B-9E99-DD1EFCC3672B Q38954642-C700B3AB-5CCF-40E1-AB26-B9C9E4D04DF4 Q39323947-F0F84988-9CA1-46EA-B178-539BD8F3B671 Q39335522-B357CE9F-5F3E-468E-900C-876DB655A3A1 Q42726715-9ACE8704-9EF9-42D7-8B7D-FE2A24340C25 Q43375910-C4968F01-1C17-4918-BEE3-E198A28DC962 Q45304644-3ECAE0F1-9D12-4109-A822-5B1F4A0617A0 Q45329805-B6D5B351-D94C-460C-9C1F-F5B5A735DA9B Q46560199-845965A6-226D-43E2-8A58-C116F11330FD Q50876872-D109316E-11AA-4F42-A2D1-01B329A7C0EC Q51781286-C83F2149-743F-46E2-BB1A-CEB3A4FF9D07

P2860

Prevalence of psychotic symptoms in a community-based Parkinson disease sample

http://www.wikidata.org/entity/Q35201060

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Prevalence of psychotic symptoms in a community-based Parkinson disease sample

@ast

Prevalence of psychotic symptoms in a community-based Parkinson disease sample

@en

type

label

Prevalence of psychotic symptoms in a community-based Parkinson disease sample

@ast

Prevalence of psychotic symptoms in a community-based Parkinson disease sample

@en

prefLabel

Prevalence of psychotic symptoms in a community-based Parkinson disease sample

@ast

Prevalence of psychotic symptoms in a community-based Parkinson disease sample

@en

P1433

Q35201060-BAE70BE4-84BE-43B3-B505-37637F2692A6

P1476

Q35201060-5FF664EB-8FB8-49D8-9C0A-0E6F858AA99F

P2093

Q35201060-2E8E683C-8DF2-4CC6-9193-2677C53BD5CC

Q35201060-47D84F23-6E17-4199-98F9-58E2108DBF67

Q35201060-573D590F-1CA6-4451-8AF7-92F909DA3991

Q35201060-576BD117-C35F-43C2-9776-8E4B7680EA3F

Q35201060-6DCB7A97-4A1E-4409-9581-0780B6B8732A

Q35201060-72DE219D-8F6F-453B-8A32-0878A466BCED

Q35201060-847E7E64-DBCA-4779-8925-7D87D9D937F6

Q35201060-A722007B-D339-4960-9151-3C413DEFF577

Q35201060-AD9EA9BF-459B-47C1-A2B9-7945EC8F6555

Q35201060-B055AAE4-5A8D-499E-BA35-C860CC2EB465

P2860

Q35201060-15F09106-7E5B-4CC9-9A57-DA68D1F7AEBF

Q35201060-18F07A75-05FA-4B84-A1AD-DD6F5F3F3C80

Q35201060-1BCB8C7E-9728-4001-B74A-608DD8B85E24

Q35201060-22FFE0A1-9A7C-46C9-A8D6-F710161AF5C3

Q35201060-2EC06774-A55A-448D-92A4-C08A26E73958

Q35201060-52A36640-C827-4382-9E8D-E283A79A05B4

Q35201060-56CAB9F6-3BCC-4E06-A908-DBCB6806889D

Q35201060-570ADD9D-608E-4D66-9F16-8CCB070F7A22

Q35201060-5FEAE4BE-9CC5-42C5-8716-D48694982FBA

Q35201060-69689303-F6A0-440B-B7AF-788BBA631F9D

P304

Q35201060-39259C66-7852-471B-8F21-1D737A43D2CC

P31

Q35201060-9649AB8A-1212-47FB-988D-F5131467D4D7

P356

Q35201060-C351D584-98D9-4790-AA4F-2AAD181A4DE5

P433

Q35201060-C1EE5C82-0459-488C-A071-D8FAD68EDA72

P478

Q35201060-3F9D9F33-3032-441D-8599-94DFA1E704C6

P577

Q35201060-E9E5BC48-A3DB-4C04-8FA2-1A63C0BEAF59

P698

Q35201060-E9AEE282-7134-423B-9928-CFC97B1A573E

P921

Q35201060-9C33CEE9-4178-468E-9B52-9DA46A9B86E7

Q35201060-D5FE6F80-D91F-4593-AB24-8B2DB177EE06

P932

Q35201060-4577899F-2493-4217-9621-F2F08FB9A970

P356

JGP.0B013E31821F1B41

P1433

American Journal of Geriatric Psychiatry

P1476

Prevalence of psychotic symptoms in a community-based Parkinson disease sample

@en

P2093

Elaina S Hirsch

http://www.w3.org/2001/XMLSchema#string

Gregory Pontone

http://www.w3.org/2001/XMLSchema#string

Howard Weiss

http://www.w3.org/2001/XMLSchema#string

James R Williams

http://www.w3.org/2001/XMLSchema#string

Joel Mack

http://www.w3.org/2001/XMLSchema#string

John T Little

http://www.w3.org/2001/XMLSchema#string

Justin Palanci

http://www.w3.org/2001/XMLSchema#string

Karen Anderson

http://www.w3.org/2001/XMLSchema#string

Laura Marsh

http://www.w3.org/2001/XMLSchema#string

Peter Rabins

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

“Mini-mental state”

Parkinsonism: onset, progression and mortality

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Prospective study of hallucinations and delusions in Parkinson's disease

A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease

Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.

The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.

Scales to assess psychosis in Parkinson's disease: Critique and recommendations.

Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease.

P304

123-132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JGP.0B013E31821F1B41

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21617521

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3168582

http://www.w3.org/2001/XMLSchema#string